INOVIO PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
INOVIO PHARMACEUTICALS, INC. (INO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$84.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$84.95M.
- INOVIO PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$107.25M.
- INOVIO PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$134.98M.
- INOVIO PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$277.44M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$84.95M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$107.25M 10-K · filed 2026-03-12 |
| 2023-12-31 | -$134.98M 10-K · filed 2025-03-18 |
| 2022-12-31 | -$277.44M 10-K · filed 2024-03-06 |
| 2021-12-31 | -$302.61M 10-K · filed 2024-03-06 |
| 2020-12-31 | -$162.66M 10-K · filed 2023-03-01 |
| 2019-12-31 | -$120.81M 10-K · filed 2022-03-01 |
| 2018-12-31 | -$94.80M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |